NCT04438980View on ClinicalTrials.gov

Glucocorticoids in COVID-19 (CORTIVID)

PHASE3CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

May 15, 2020

Primary Completion Date

March 12, 2021

Study Completion Date

April 9, 2021

Conditions
Covid-19 Pneumonia
Interventions
DRUG

Methylprednisolone

-A dose of 120 mg/day of methylprednisolone for 3 days, administered by intravenous infusión

OTHER

Placebo

-An infusion bag of 100 mL of 0.9% saline

Trial Locations (2)

31008

Complejo Hospitalario de Navarra, Pamplona

Unknown

Hospital Sant Joan Despí Moisès Broggi, Sant Joan Despí

All Listed Sponsors
collaborator

Complejo Hospitalario de Navarra

OTHER

collaborator

Hospital Sant Joan Despí Moisès Broggi

UNKNOWN

lead

Fundacion Miguel Servet

OTHER

NCT04438980 - Glucocorticoids in COVID-19 (CORTIVID) | Biotech Hunter | Biotech Hunter